Group One Trading, L.P. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Group One Trading, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$83.14 - $145.99 $640,094 - $1.12 Million	-7,699 Reduced 66.49%	3,881 $566,000
Q1 2022 May 12, 2022	BUY	$110.08 - $142.92 $1.27 Million - $1.66 Million	11,580 New	11,580 $1.37 Million
Q1 2021 May 12, 2021	SELL	$64.07 - $91.75 $2.47 Million - $3.54 Million	-38,581 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$65.07 - $98.24 $1.81 Million - $2.73 Million	27,752 Added 256.27%	38,581 $3.31 Million
Q3 2020 Nov 12, 2020	BUY	$59.04 - $77.95 $97,356 - $128,539	1,649 Added 17.96%	10,829 $704,000
Q2 2020 Aug 13, 2020	SELL	$29.01 - $74.23 $97,154 - $248,596	-3,349 Reduced 26.73%	9,180 $671,000
Q1 2020 May 13, 2020	SELL	$27.51 - $57.29 $1.15 Million - $2.4 Million	-41,975 Reduced 77.01%	12,529 $426,000
Q4 2019 Feb 10, 2020	SELL	$40.86 - $57.65 $1.39 Million - $1.96 Million	-33,917 Reduced 38.36%	54,504 $2.97 Million
Q3 2019 Nov 12, 2019	SELL	$37.38 - $49.47 $539,243 - $713,654	-14,426 Reduced 14.03%	88,421 $3.69 Million
Q2 2019 Aug 09, 2019	BUY	$39.79 - $67.01 $4.09 Million - $6.89 Million	102,847 New	102,847 $4.5 Million
Q4 2018 Feb 06, 2019	SELL	$29.75 - $42.9 $50,634 - $73,015	-1,702 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$32.79 - $43.0 $104,993 - $137,686	-3,202 Reduced 65.29%	1,702 $64,000
Q2 2018 Aug 14, 2018	SELL	$23.62 - $42.29 $1.45 Million - $2.6 Million	-61,596 Reduced 92.63%	4,904 $194,000
Q1 2018 May 11, 2018	BUY	$22.49 - $34.56 $1.5 Million - $2.3 Million	66,500 New	66,500 $1.71 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.